Organon (OGN) Exchange Rate Effect (2021 - 2026)
Organon (OGN) posted quarterly Exchange Rate Effect of -$3.0 million for Q2 2026, down 103.23% year-over-year from $93.0 million in Q2 2025, and up 90.32% on a QoQ basis from -$31.0 million in Q1 2026.
Organon (OGN) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Organon has reported Exchange Rate Effect for 7 years, with the latest figure at -$3.0 million in Q2 2026.
- Exchange Rate Effect for Q2 2026 came in at -$3.0 million, down 103.23% year-over-year; the trailing twelve-month figure through Jun 2026 was -$21.0 million (down 119.44% YoY), and the FY2025 annual result was $150.0 million, up 297.37% from the prior year.
- Exchange Rate Effect grew to -$3.0 million in Q2 2026, from -$31.0 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $93.0 million in Q2 2025 and troughed at -$100.0 million in Q4 2024.
- A 5-year average of $1.2 million and a median of -$3.0 million in 2026 frame the typical range for Exchange Rate Effect.
- The widest annual swing landed in 2022, when Exchange Rate Effect soared 4050.0%; it then slumped 1050.0% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $83.0 million in 2022, then slumped by 51.81% to $40.0 million in 2023, then slumped by 350.0% to -$100.0 million in 2024, then surged by 113.0% to $13.0 million in 2025, then tumbled by 123.08% to -$3.0 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$3.0 million in Q2 2026, -$31.0 million in Q1 2026, and $13.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.61 Bn | 630.85 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 470.09 Bn | 463.53 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 374.19 Bn | 367.05 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 302.72 Bn | 295.03 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 257.19 Bn | 252.29 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 236.77 Bn | 222.78 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.67 Bn | 179.49 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 159.54 Bn | 147.84 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 105.97 Bn | 101.81 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.00 Mn |
| Jun 30, 2026 | -3.00 Mn |
| Mar 31, 2026 | -31.00 Mn |
| Mar 31, 2026 | -31.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Dec 31, 2023 | 40.00 Mn |